Proportion of isolates with decreased susceptibility or resistance in Australia

Australia: Proportion of isolates with decreased susceptibility or resistance was 0.01 in 2020. ◆ Volatile

Latest (2020)
0.01
Change on year
down 85.0%
World rank
12th
of 52 countries
All-time high
1.71
in 2016
All-time low
0.01
in 2020
Years of data
11
2009–2020

Proportion of isolates with decreased susceptibility or resistance in Australia, 2009–2020

00.511.52009201420202009: 0.0322010: 0.1242011: 0.1462012: 0.2972013: 0.5722014: 0.5932015: 0.0552016: 1.72017: 0.0382018: 0.0672020: 0.01

Source: World Health Organization, Global Health Observatory.

Analysis

In 2020, proportion of isolates with decreased susceptibility or resistance in Australia stood at 0.01. That is the lowest value across all 11 years on record.

Compared with earlier readings it is down 85.0% on the previous year and down 91.9% over ten years.

Over the whole period, proportion of isolates with decreased susceptibility or resistance in Australia peaked at 1.71 in 2016 and was at its lowest, 0.01, in 2020.

That places Australia 12th out of 52 countries with data for 2020, putting it in the top quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Proportion of isolates with decreased susceptibility or resistance in Australia, year by year

Annual values for Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP in Australia, 2009 to 2020.
Year Value Change
2009 0.0317
2010 0.1242 +292.1%
2011 0.1461 +17.6%
2012 0.2967 +103.1%
2013 0.5718 +92.7%
2014 0.5926 +3.6%
2015 0.0554 -90.6%
2016 1.71 +2982.6%
2017 0.0383 -97.8%
2018 0.0666 +74.0%
2020 0.01 -85.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.0317 0.0317 0.0317 1
2010s 0.4001 0.0383 1.71 9
2020s 0.01 0.01 0.01 1

Countries ranked near Australia

  1. 9 Mongolia 0.7752 compare
  2. 10 Belgium 0.6 compare
  3. 11 New Zealand 0.1 compare
  4. 13 Korea 0 compare
  5. 13 Argentina 0 compare
  6. 13 Croatia 0
  7. 13 Pakistan 0 compare
  8. 13 Ireland 0 compare
  9. 13 Chile 0
  10. 13 Poland 0
  11. 13 Latvia 0
  12. 13 Slovenia 0 compare
  13. 13 Malta 0
  14. 13 Thailand 0 compare
  15. 13 United Kingdom of Great Britain and Northern Ireland 0
  16. 13 Colombia 0
  17. 13 Cyprus 0
  18. 13 Spain 0 compare
  19. 13 United States of America 0 compare
  20. 13 Paraguay 0
  21. 13 Belarus 0
  22. 13 Philippines 0 compare
  23. 13 Slovakia 0
  24. 13 Sweden 0
  25. 13 Greece 0 compare
  26. 13 France 0
  27. 13 Denmark 0
  28. 13 South Africa 0
  29. 13 Norway 0
  30. 13 India 0 compare
  31. 13 Dominican Republic 0
  32. 13 Austria 0 compare
  33. 13 Peru 0 compare
  34. 13 Côte d'Ivoire 0
  35. 13 Germany 0 compare
  36. 13 Hungary 0
  37. 13 Iceland 0
  38. 13 Sri Lanka 0
  39. 13 Italy 0
  40. 13 Panama 0
  41. 13 Portugal 0
  42. 13 Netherlands 0
  43. 13 Estonia 0

See the full ranking of 52 places →

More health data for Australia

All data for Australia →

Frequently asked questions

What is proportion of isolates with decreased susceptibility or resistance in Australia?
Proportion of isolates with decreased susceptibility or resistance in Australia was 0.01 in 2020, according to World Health Organization, Global Health Observatory.
What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Australia?
The highest recorded value was 1.71 in 2016.
What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Australia?
The lowest recorded value was 0.01 in 2020.
How does Australia rank for proportion of isolates with decreased susceptibility or resistance?
Australia ranks 12th out of 52 countries with data for 2020.
Is proportion of isolates with decreased susceptibility or resistance rising or falling in Australia?
Over the last ten years it is down 91.9%. The long-run trend across the full record is volatile.
Where does this Australia data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 11 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Proportion of isolates with decreased susceptibility or resistance in Australia. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 12 September 2026, from https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-ceftriaxone/australia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-ceftriaxone/australia/">Proportion of isolates with decreased susceptibility or resistance in Australia</a> — Statizoid

About this data

Indicator
Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
52 places, 454 data points, 2009–2020
Last refreshed